[
    {
        "content": "* Advanced Accelerator Applications reports 39% sales growth for third quarter 2017",
        "date": "11172017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications reports qtrly loss per share EUR\u200b \u200d0.26 "
    },
    {
        "content": "ZURICH Novartis has agreed to buy French-based Advanced Accelerator Applications (AAA) for $3.9 billion  giving it a platform in radiopharmaceuticals and access to a new therapy for the kind of cancer that killed Steve Jobs.",
        "date": "10302017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "Novartis to buy French cancer specialist AAA for $3.9 billion "
    },
    {
        "content": "* French company had first-half sales of $78 mln (Adds Breakingviews link  further detail on Novartis cancer drugs)",
        "date": "10302017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "normal",
        "symbol": "AAAP",
        "title": "UPDATE 3-Novartis to buy French cancer specialist AAA for $3.9 bln "
    },
    {
        "content": "* Advanced accelerator applications announces $3.9 billion all cash proposed tender offer by Novartis",
        "date": "10302017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "normal",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator announces $3.9 bln all cash proposed tender offer by Novartis "
    },
    {
        "content": "LONDON/FRANKFURT  Nov 2 Swiss drugmaker Novartis is working with Centerview to review options for its dermatology business  including a possible sale  as it trims non-core assets  two sources familiar with the matter told Reuters.",
        "date": "11022017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "normal",
        "symbol": "AAAP",
        "title": "Novartis picks Centerview to explore sale of dermatology unit -sources "
    },
    {
        "content": "* Advanced Accelerator Applications announces European approval of lutetium (177lu) oxodotreotide (lutathera\u00ae) for gastroenteropancreatic neuroendocrine (gep-net) tumors",
        "date": "09292017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator announces European approval of lutetium  oxodotreotide for gastroenteropancreatic neuroendocrine tumors "
    },
    {
        "content": "* Advanced Accelerator Applications reports 32% sales growth for second quarter 2017",
        "date": "08312017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications reports 32 pct sales growth in Q2 "
    },
    {
        "content": "NEW YORK Retail U.S. gasoline prices rose to $2.59 a gallon on Saturday in the wake of Hurricane Harvey  according to motorists advocacy group AAA.",
        "date": "09022017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "U.S. average retail gasoline price rises to $2.59/gallon: AAA "
    },
    {
        "content": "* Advanced accelerator applications completes resubmission of NDA for lutetium lu 177 dotatate (lutathera\u00ae) to FDA",
        "date": "07272017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications completes resubmission of NDA "
    },
    {
        "content": "* Advanced Accelerator Applications reports 21% sales growth for first quarter 2017",
        "date": "05312017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications' Q1 sales $34.9 million "
    },
    {
        "content": "* Advanced Accelerator Applications signs strategic supply agreement with University Of Missouri for lutetium 177",
        "date": "03302017",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications signs strategic supply agreement with University of Missouri "
    },
    {
        "content": "* Advanced accelerator applications reports 15.4% sales growth in the third quarter of 2016 and feedback from the FDA for lutathera\u007f  an investigational treatment for Neuroendocrine tumors",
        "date": "11282016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications reports 15.4% sales growth "
    },
    {
        "content": "* Advanced Accelerator Applications announces positive EMA opinion on application for SomaKit TOC",
        "date": "10172016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator announces positive EMA opinion on application for SomaKit TOC "
    },
    {
        "content": "* Advanced accelerator applications s.a. Announces pricing of $150 million public offering of american depositary shares",
        "date": "10062016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications announces pricing of $150 mln public offering of ADS "
    },
    {
        "content": "* Advanced accelerator applications sa says has commenced an underwritten public offering of $125 million of american depositary shares",
        "date": "10042016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications S.A.- proposed public offering of ADS "
    },
    {
        "content": "* Advanced Accelerator Applications announces revised EMA review timeline for Lutathera\u007f",
        "date": "09202016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications announces revised EMA review timeline for Lutathera "
    },
    {
        "content": "* Advanced Accelerator Applications announces positive EMA opinion on application for SomaKit TOC kit for radiopharmaceutical preparation of gallium (Ga 68) edotreotide for gastroenteropancreatic neuroendocrine tumor detection",
        "date": "09162016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications announces positive EMA opinion on application for SomaKit TOC "
    },
    {
        "content": "* Advanced Accelerator Applications reports 24.4% sales growth in the second quarter of 2016",
        "date": "08312016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications reports 24.4% sales growth in Q2 "
    },
    {
        "content": "* Advanced accelerator applications announces FDA priority review for Lutathera",
        "date": "06272016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications announces FDA priority review for Lutathera "
    },
    {
        "content": "* Advanced Accelerator Applications S.A. says selected Cardinal Health to supply Gallium 68 dotatate doses to u.s. Hospitals and imaging centers  Source text for Eikon:  Further company coverage:    )",
        "date": "06092016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Cardinal Health to prepare NETSPOT doses for Advanced Accelerator Applications "
    },
    {
        "content": "* Advanced Accelerator Applications announces expansion of theranostic pipeline with neoBOMB1  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom: +1-646-223-8780)",
        "date": "06072016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications expands theranostic pipeline with neoBOMB1 "
    },
    {
        "content": "* Advanced accelerator applications reports 29.6 pct sales growth in the first quarter of 2016",
        "date": "05312016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Q1 sales rose 29.6 pct to EUR26.92 mln "
    },
    {
        "content": "* Advanced Accelerator Applications appoints Francois Nader to board of directors  Source text for Eikon:  Further company coverage:    (Bengaluru Newsroom: +1 646 223 8780)",
        "date": "05262016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications appoints Francois Nader to board "
    },
    {
        "content": "* Advanced accelerator applications reports 26.8% sales growth in 2015 and continues to show significant clinical progress across both therapeutic and diagnostic platforms",
        "date": "04292016",
        "name": "Advanced Accelerator Applications SA",
        "news_type": "topStory",
        "symbol": "AAAP",
        "title": "BRIEF-Advanced Accelerator Applications reports 26.8 pct sales growth in 2015 "
    }
]